DKK 3.24
(1.57%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 24.99 Million DKK | -48.1% |
2022 | 48.15 Million DKK | 53.43% |
2021 | 31.38 Million DKK | -6.02% |
2020 | 33.39 Million DKK | 14.06% |
2019 | 29.28 Million DKK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 28.12 Million DKK | 0.0% |
2024 Q1 | 28.12 Million DKK | 12.54% |
2023 Q2 | 35.17 Million DKK | 0.0% |
2023 Q1 | 35.17 Million DKK | -26.95% |
2023 FY | 24.99 Million DKK | -48.1% |
2023 Q4 | 24.99 Million DKK | 0.0% |
2023 Q3 | 24.99 Million DKK | -28.95% |
2022 Q4 | 48.15 Million DKK | -0.0% |
2022 FY | 48.15 Million DKK | 53.43% |
2022 Q2 | 39.37 Million DKK | 0.0% |
2022 Q1 | 39.37 Million DKK | 25.44% |
2022 Q3 | 48.15 Million DKK | 22.31% |
2021 Q1 | - DKK | 0.0% |
2021 FY | 31.38 Million DKK | -6.02% |
2021 Q3 | 31.38 Million DKK | -25.88% |
2021 Q2 | 42.34 Million DKK | 0.0% |
2021 Q4 | 31.38 Million DKK | -0.0% |
2020 FY | 33.39 Million DKK | 14.06% |
2019 FY | 29.28 Million DKK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Flügger group A/S | 1.11 Billion DKK | 97.765% |
Novozymes A/S | 14.04 Billion DKK | 99.822% |
SP Group A/S | 1.55 Billion DKK | 98.394% |